Superficial femoral artery occlusion
|
disease |
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Complicated appendicitis
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hypersomnolence
|
phenotype |
Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
7
|
|
0.010 |
None |
< 0.001 |
1 |
|
2011 |
2011 |
Primary Hyperthyroidism
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
10
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Increased waist to hip ratio
|
phenotype |
|
Finding
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive Type
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
12
|
1
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Decreased resting energy expenditure
|
phenotype |
|
Finding
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
Disorder of endocrine ovary
|
group |
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Disease or Syndrome
|
22
|
1
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Cytokine Release Syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Chemically-Induced Disorders
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
HEMIHYPERPLASIA, ISOLATED
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
31
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Methamphetamine dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
33
|
9
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Chronic Total Occlusion Vessel
|
disease |
|
Disease or Syndrome
|
33
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Microvascular Angina
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
39
|
10
|
0.010 |
None |
< 0.001 |
1 |
|
2000 |
2000 |
Morphine Dependence
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
44
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Atresia
|
disease |
|
Congenital Abnormality
|
44
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Anxiety States, Neurotic
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
44
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Alcohol-Related Disorders
|
group |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
54
|
180
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Febrile Neutropenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
58
|
14
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Acute myeloid leukaemia refractory
|
disease |
Neoplasms
|
Neoplastic Process
|
58
|
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Invasive aspergillosis
|
disease |
Infections
|
Disease or Syndrome
|
59
|
13
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Anxiety neurosis (finding)
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
75
|
5
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Opiate Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
46
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Allodynia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Finding
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyperalgesia, Primary
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
84
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant ascites
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
86
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |